fashion -WSS

fashion

author：focus 2025-09-03 12:07:45 - browse：7164

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Wikipedia

WSS

HHS names first

Idaho abortion case may prompt more restrictions in other states

Judge in Trump's classified documents case questions use of out

Google's generative AI to analyze medical images — and talk to docs

Slovenia has suffered its worst

Doctors are clamoring for more clarity on Paxlovid prescribing

hotspot

fashion

leisure time

Continuity nursing helped my family in our darkest PICU moments

Doctors push to include dialysis machines in emergency stockpile

Medical records are filled with copy

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Apple is now the first public company to be valued at $3 trillion

Feed a cold, starve a fever? Here’s what science says

How to save PrEP access — and even expand it

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Sports medicine is finally prioritizing gender equality

The nurse manager staffing crisis is hurting patients

knowledge

Sweden knocks USA out of World Cup in penalty kicks

Failure, not just success, should guide future doctors

Generative AI mines health records to identify patients’ social needs

Many breast cancer patients receive more radiation than needed

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

JPM 2024: Verve Therapeutics looks to mainstream genome editing

entertainment

Wikipedia

focus

leisure time